Amgen Inc. is a global biotechnology company headquartered in Thousand Oaks, California. Founded in 1980, Amgen is dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. It is known for pioneering advances in biotechnology to treat serious illnesses by harnessing the power of cellular and molecular biology.

Amgen’s product portfolio focuses on therapies for oncology, nephrology, rheumatology, and other serious diseases, aiming to improve patient outcomes and quality of life. The company is committed to scientific excellence and innovation, investing significantly in research and development to bring new medicines to patients worldwide.

With a presence in numerous countries, Amgen operates state-of-the-art manufacturing facilities and offices globally, including major sites in the United States, China, and other regions. The company values a patient-centric approach combined with operational excellence and ethical standards.

Amgen continues to expand its impact in biotechnology, emphasizing sustainability, corporate responsibility, and collaboration within the healthcare ecosystem to address unmet medical needs and transform lives through science.